Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

OBJECTIVE: To evaluate pharmaceutical bioequivalence between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions. MATERIAL AND METHODS: An open label, monocentric, randomized, 2x2 crossover study in 32 healthy men under fasting conditions compari...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: Carlos Sverdloff, Vinicius Marcondes Rezende, Ligia de Cassia Val, Nelly Cristina Castro, Maria Elena Cedano Limón, Mohammad H. Badii, Sreekanth Kakarla, Murali Pendela, Lygia Bonnato
Ձևաչափ: Հոդված
Լեզու:English
Հրապարակվել է: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2023-12-01
Շարք:Brazilian Journal of Oncology
Խորագրեր:
lenalidomide
therapeutic equivalency
antineoplastic agents
Առցանց հասանելիություն:https://www.brazilianjournalofoncology.com.br/details/266/en-US/bioequivalence-study-between-two-formulations-of-10mg-lenalidomide-capsules-in-healthy-male-subjects-under-fasting-conditions

Համացանց

https://www.brazilianjournalofoncology.com.br/details/266/en-US/bioequivalence-study-between-two-formulations-of-10mg-lenalidomide-capsules-in-healthy-male-subjects-under-fasting-conditions

Նմանատիպ նյութեր